Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.38B |
| 2 |
NVIDIA
NVDA
|
+$732M |
| 3 |
Amazon
AMZN
|
+$606M |
| 4 |
Walt Disney
DIS
|
+$559M |
| 5 |
AT&T
T
|
+$466M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$1.41B |
| 2 |
Comcast
CMCSA
|
+$658M |
| 3 |
Boston Scientific
BSX
|
+$650M |
| 4 |
Palo Alto Networks
PANW
|
+$642M |
| 5 |
T-Mobile US
TMUS
|
+$577M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.81% |
| 2 | Healthcare | 2.95% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.15% |
| 5 | Industrials | 1.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AUGX
8376
DELISTED
Augmedix, Inc. Common Stock
AUGX
| $420K | ﹤0.01% |
71,843
+52,211
| +266% | +$275K |
|
8377
CALL
Ambev
ABEV
$42.9B
| $420K | ﹤0.01% |
150,100
-28,400
| -16% | -$76.7K |
|
8378
Mohr Sector Nav ETF
SNAV
$30.2M
| $420K | ﹤0.01% |
+15,297
| New | +$404K |
|
8379
Vanguard Long-Term Bond ETF
BLV
$5.68B
| $420K | ﹤0.01% |
5,632
+490
| +10% | +$33.6K |
|
8380
iShares MSCI Sweden ETF
EWD
$746M
| $420K | ﹤0.01% |
10,636
-27,830
| -72% | -$973K |
|
8381
Direxion Daily Transportation Bull 3X ETF
TPOR
$18.2M
| $420K | ﹤0.01% |
12,806
-1,609
| -11% | -$41.6K |
|
8382
FT Vest US Small Cap Moderate Buffer ETF May
SMAY
$112M
| $419K | ﹤0.01% |
19,050
+5
| +0% | +$103 |
|
8383
CALL
Fidelity MSCI Energy Index ETF
FENY
$2.14B
| $419K | ﹤0.01% |
18,200
+8,200
| +82% | +$193K |
|
8384
PUT
Clover Health Investments
CLOV
$2.25B
| $419K | ﹤0.01% |
440,400
+48,900
| +12% | +$48K |
|
8385
CALL
Olema Pharmaceuticals
OLMA
$932M
| $418K | ﹤0.01% |
29,800
+7,600
| +34% | +$102K |
|
8386
PUT
United States 12 Month Oil Fund,
USL
$47M
| $418K | ﹤0.01% |
11,900
+7,600
| +177% | +$284K |
|
|
LTC
8387
PUT
LTC Properties
LTC
$2.16B
| $418K | ﹤0.01% |
13,000
+5,400
| +71% | +$175K |
|
8388
Rekor Systems
REKR
$84M
| $417K | ﹤0.01% |
125,303
+10,483
| +9% | +$29.9K |
|
|
WNS
8389
CALL
DELISTED
WNS Holdings
WNS
| $417K | ﹤0.01% |
6,600
-10,000
| -60% | -$611K |
|
8390
PUT
VanEck BDC Income ETF
BIZD
$1.69B
| $417K | ﹤0.01% |
26,000
+6,600
| +34% | +$103K |
|
8391
ROBO Global Healthcare Technology and Innovation ETF
HTEC
$73.2M
| $417K | ﹤0.01% |
14,871
-4,522
| -23% | -$112K |
|
8392
PUT
Clarivate
CLVT
$1.21B
| $417K | ﹤0.01% |
45,000
-11,700
| -21% | -$86.5K |
|
8393
CALL
Cohen & Steers
CNS
$4.26B
| $417K | ﹤0.01% |
5,500
-3,200
| -37% | -$193K |
|
|
ESPR
8394
PUT
DELISTED
Esperion Therapeutics
ESPR
| $416K | ﹤0.01% |
139,200
+86,200
| +163% | +$112K |
|
8395
CALL
Ingevity
NGVT
$2.54B
| $416K | ﹤0.01% |
8,800
-6,900
| -44% | -$287K |
|
|
QQJG
8396
DELISTED
Invesco ESG NASDAQ Next Gen 100 ETF
QQJG
| $416K | ﹤0.01% |
+19,977
| New | +$380K |
|
8397
Molina Healthcare
MOH
$10.6B
| $416K | ﹤0.01% |
1,150
-1,514
| -57% | -$534K |
|
8398
CALL
Red Robin
RRGB
$193M
| $415K | ﹤0.01% |
33,300
-16,200
| -33% | -$151K |
|
8399
PUT
Magnite
MGNI
$3.52B
| $415K | ﹤0.01% |
44,400
-4,900
| -10% | -$38.7K |
|
|
PRFT
8400
PUT
DELISTED
Perficient Inc
PRFT
| $415K | ﹤0.01% |
6,300
| – | – |
|
Similar funds
Ken Griffin's Q4 2023 Portfolio in Review
As of Q4 2023, Ken Griffin held 15,795 positions worth $500B, up 7.2% from $467B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $25.4B in Q4 2023, closing 1,624 positions and reducing 6,315 holdings. Its most notable exit was Activision Blizzard, an estimated $1.41B position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Ken Griffin opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $129M.
- Ken Griffin's largest Q4 2023 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,167,658 shares worth $129M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $1.38B increase.
- Ken Griffin's biggest Q4 2023 reduction was Comcast, cutting an estimated $658M.
- Ken Griffin fully exited Activision Blizzard in Q4 2023, selling an estimated $1.41B.
- Ken Griffin's ten largest holdings make up 31% of its $500B portfolio in Q4 2023.
- Ken Griffin opened 1,585 new positions and closed 1,624 in Q4 2023.
- Ken Griffin's portfolio value rose 7.2% quarter-over-quarter to $500B.
Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.